Zurcher Kantonalbank Zurich Cantonalbank Purchases 32,308 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 492,468 shares of the pharmacy operator’s stock after acquiring an additional 32,308 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank owned 0.06% of Walgreens Boots Alliance worth $4,595,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp boosted its holdings in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after buying an additional 2,185,950 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Walgreens Boots Alliance by 12.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after acquiring an additional 817,762 shares during the period. Thompson Siegel & Walmsley LLC grew its position in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after acquiring an additional 934,754 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in Walgreens Boots Alliance by 9.6% during the fourth quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after acquiring an additional 478,061 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $11.23 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The stock has a market capitalization of $9.70 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62. The business has a 50-day moving average price of $10.83 and a two-hundred day moving average price of $9.76.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

WBA has been the topic of several analyst reports. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Bank of America raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.